NewsBenzingaInnoviz Technologies révise à la baisse ses prévisions de ventes pour l’exercice 2026, passant de 67,000 M$–73,000 M$ à 44,000 M$–46,000 M$, contre 70,000 M$ estimés Innoviz Technologies révise à la baisse ses prévisions de ventes pour l’exercice 2026, passant de 67,000 M$–73,000 M$ à 44,000 M$–46,000 M$, contre 70,000 M$ estimés Benzinga 2026.11.11 12:05 (GMT+0) Open on Benzinga Other news StoneX Maintains Buy on Rivian Automotive, Lowers Price Target to $20 Amer Sports Unleashes $1 Billion Buyback, Raises 2026 Outlook EXCLUSIVE: Tesla Still Rules Leveraged ETFs, but Anthropic IPO and Micron’s Rise Signal What’s Next StoneX Reiterates Hold on iQIYIto Hold StoneX Maintains Buy on Baidu, Lowers Price Target to $125 Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide
Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide